Is there fibrinogen in Fresh Frozen Plasma (FFP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fibrinogen Content in Fresh Frozen Plasma (FFP)

Yes, FFP contains fibrinogen at a concentration of approximately 2.5-3.0 g/L (or even less: 0.9-2.0 g/L after thawing), making it a source of fibrinogen, though at relatively low concentrations compared to cryoprecipitate or fibrinogen concentrates. 1

Fibrinogen Content in Different Blood Products

Fresh Frozen Plasma (FFP)

  • Contains all soluble coagulation factors, including fibrinogen
  • Fibrinogen concentration: 2.5-3.0 g/L (or 0.9-2.0 g/L after thawing) 1
  • Approximately 2 g of fibrinogen in four units of FFP 2
  • Due to this relatively low concentration, FFP is considered unsuitable for significant fibrinogen replenishment in severe hypofibrinogenemia 1

Alternative Sources of Fibrinogen

  1. Cryoprecipitate

    • Higher concentration of fibrinogen: 15-17 g/L 1
    • Contains other factors: von Willebrand factor, factor VIII, and factor XIII
    • Dosing: Generally, two units of cryoprecipitate per 10 kg of body weight raise plasma fibrinogen by 1 g/L 1
  2. Fibrinogen Concentrate

    • Highest concentration: 20 g/L when reconstituted according to manufacturer guidelines 1
    • Virus-inactivated derivative of pooled plasma
    • Provides more predictable amounts of fibrinogen than cryoprecipitate 1

Clinical Implications

When to Use FFP as a Source of Fibrinogen

FFP is administered as a source of coagulation factors, including fibrinogen, primarily in:

  • Major hemorrhage, often in a balanced ratio with red blood cells (1:1 or 1:1.5) 1
  • Disseminated intravascular coagulation (DIC) with active bleeding 1
  • Reversal of warfarin anticoagulation when prothrombin complex concentrate is unavailable 1
  • Replacement fluid for apheresis in microangiopathies 1

When Alternative Sources Are Preferred

For significant hypofibrinogenemia requiring targeted fibrinogen replacement:

  • Cryoprecipitate or fibrinogen concentrate is recommended when fibrinogen levels are low (<1.5 g/L) with clinically significant bleeding 1
  • In obstetric hemorrhage, fibrinogen levels should be maintained above 2 g/L 1

Important Considerations

Stability of Fibrinogen in FFP

  • Fibrinogen in FFP remains stable even after repeated freezing and thawing cycles 3
  • Studies show that vitamin K-dependent factors and fibrinogen levels remain adequate for transfusion in twice-thawed-and-refrozen FFP 3

Clinical Outcomes

  • In trauma patients with coagulopathy, fibrinogen concentrate has shown better outcomes than FFP regarding mortality, sepsis, need for ICU admission, and duration of hospitalization 4
  • In pediatric cardiac surgery, FFP in the pump prime can limit dilutional hypofibrinogenemia 5

Common Pitfalls

  1. Inappropriate Use of FFP

    • FFP should not be used solely for volume replacement 1
    • Not recommended for prophylactic correction of abnormal coagulation tests prior to low-risk procedures in critically ill patients 1
    • Not recommended for prophylactic use in elective cardiac surgery 1
  2. Dosing Considerations

    • The recommended therapeutic dose of FFP is 15 ml/kg 2
    • Administration should be guided by clinical response in actively bleeding patients
  3. Blood Group Compatibility

    • Donor and recipient blood groups should be the same for FFP transfusion
    • If patient's blood group is unknown, ABO non-identical plasma with "low titre" anti-A or anti-B activity is acceptable 1
    • Group O components should only be given to group O recipients 1

In summary, while FFP does contain fibrinogen, its relatively low concentration makes it less suitable than cryoprecipitate or fibrinogen concentrate for significant fibrinogen replacement in cases of severe hypofibrinogenemia.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.